We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

172 hedge funds and large institutions have $997M invested in Arcus Biosciences in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 59 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more call options, than puts

Call options by funds: $5.35M | Put options by funds: $3.19M

3% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 59

2% less capital invested

Capital invested by funds: $1.02B → $997M (-$25.2M)

7% less funds holding

Funds holding: 185 → 172 (-13)

13.37% less ownership

Funds ownership: 71.53% → 58.16% (-13%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

39% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 31

Holders
172
Holders Change
-13
Holders Change %
-7.03%
% of All Funds
2.48%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
61
Reduced
59
Closed
31
Calls
$5.35M
Puts
$3.19M
Net Calls
+$2.16M
Net Calls Change
-$5.09M

Top Buyers

1
WP
Woodline Partners
California
+$31.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.8M
3
State Street
State Street
Massachusetts
+$11.5M
4
LCM
Laurion Capital Management
New York
+$9.47M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.43M

Top Sellers

1
OCA
Octagon Capital Advisors
New York
-$35.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.85M
3
Morgan Stanley
Morgan Stanley
New York
-$9.13M
4
Ameriprise
Ameriprise
Minnesota
-$7.5M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$6.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
51
Allianz Asset Management
Germany
$1.86M +$1.3M +75,000 +322%
PP
52
PDT Partners
New York
$1.83M +$1.42M +82,178 +549%
Swiss National Bank
53
Swiss National Bank
Switzerland
$1.8M – – –
SAM
54
Sectoral Asset Management
Quebec, Canada
$1.77M -$65.7K -3,800 -4%
PA
55
Parallel Advisors
California
$1.62M +$1.3K +75 +0.1%
Norges Bank
56
Norges Bank
Norway
$1.51M – – –
Victory Capital Management
57
Victory Capital Management
Texas
$1.42M -$503K -29,087 -28%
Jane Street
58
Jane Street
New York
$1.41M -$4.44M -256,581 -77%
Group One Trading
59
Group One Trading
Illinois
$1.41M +$319K +18,470 +33%
FAM
60
Fred Alger Management
New York
$1.39M -$29.2K -1,689 -2%
D.E. Shaw & Co
61
D.E. Shaw & Co
New York
$1.28M +$1.17M +67,542 New
UOC
62
UBS O'Connor
Illinois
$1.21M +$188K +10,876 +20%
AA
63
ALPS Advisors
Colorado
$1.21M +$201K +11,619 +22%
Prudential Financial
64
Prudential Financial
New Jersey
$1.2M +$18.2K +1,050 +2%
AG
65
Algert Global
California
$1.1M -$394K -22,790 -28%
American Century Companies
66
American Century Companies
Missouri
$1.09M +$106K +6,139 +12%
WG
67
Winton Group
United Kingdom
$1.08M +$990K +57,265 New
Massachusetts Financial Services
68
Massachusetts Financial Services
Massachusetts
$1.06M -$2.14K -124 -0.2%
PA
69
Profund Advisors
Maryland
$1.03M +$195K +11,265 +26%
Two Sigma Advisers
70
Two Sigma Advisers
New York
$959K +$297K +17,200 +51%
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$928K -$49K -2,831 -5%
CS
72
Credit Suisse
Switzerland
$893K – – –
TPSF
73
Texas Permanent School Fund
Texas
$889K +$9.46K +547 +1%
Thrivent Financial for Lutherans
74
Thrivent Financial for Lutherans
Minnesota
$885K -$19.6K -1,131 -2%
Canada Life
75
Canada Life
Manitoba, Canada
$876K – – –
1 2
3
4 5

RCUS Hedge Fund Activity: Q1 2024 in Review

172 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2024, worth a combined $997M — down 2.5% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of RCUS and 19 opened new positions — a net loss of 12 holders — while 59 trimmed existing stakes and 61 added.

The largest buyer was Woodline Partners, adding an estimated $31.9M. The largest seller was Octagon Capital Advisors, exiting entirely with an estimated $35.7M sold.

  • 172 institutional investors held Arcus Biosciences (RCUS) as of Q1 2024, down from 185 in Q4 2023.
  • Funds reported $997M of Arcus Biosciences stock for Q1 2024, down 2.5% quarter-over-quarter.
  • 19 funds opened new Arcus Biosciences positions in Q1 2024 and 31 closed out, a net change of -12 holders.
  • The largest Arcus Biosciences buyer in Q1 2024 was Woodline Partners, an estimated $31.9M added.
  • The largest Arcus Biosciences seller in Q1 2024 was Octagon Capital Advisors, an estimated $35.7M sold.

Based on aggregated 13F filings for Q1 2024.